Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil

Journal Title: Revista Uningá - Year 2024, Vol 61, Issue 1

Abstract

COVID-19, caused by the SARS-CoV-2 virus, is a global respiratory syndrome with high mortality rates. Vaccination is currently the only proven method to prevent the disease, although the role of lab data in assessing efficacy remains uncertain. This study aimed to assess spike-binding and neutralizing antibody levels following full vaccination with Oxford/AstraZeneca (ChAdOx1 nCoV-19) or CoronaVac in healthcare workers in southeastern Brazil. ChAdOx1 nCoV-19 and CoronaVac induced IgG antibodies against trimeric spike glycoproteins in 99.5% and 80.9% of individuals, respectively. Neutralizing antibodies were produced against two viral strains groups: variants group 1 (Wuhan-Hu-1, Alpha) and variants group 2 (Beta, Gamma) with neutralization rates of 88.3% and 78.2% for ChAdOx1 nCoV-19, and 68.1% and 48.9% for CoronaVac. No associations were found between neutralizing levels and comorbidities, age, or side effects. A positive correlation was observed between IgG antibody concentrations against trimeric spike glycoproteins and neutralizing levels for both vaccines and variants. These findings indicate that both vaccines induced reasonable levels of neutralizing antibodies against variants group 1, but only ChAdOx1 nCoV-19 maintained acceptable levels against a variant strain. The study suggests that evaluating vaccine responses to different pathogen strains can aid in managing healthcare workforce concerns and improve vaccine selection, thereby enhancing overall vaccination strategies.

Authors and Affiliations

Maicon Jeferson Silva de Oliveira, Beatriz Birelli do Nascimento, Fernanda de Assis Oliveira, Mahelly Bueno de Almeida, Márcio Rodrigues, Flavia Cristina Cardoso Carvalho, Éric Diego Barioni, Rodrigo Azevedo Loiola, Rômulo Tadeu Dias de Oliveira, Gustavo Henrique Oliveira da Rocha

Keywords

Related Articles

The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment

Adverse effects caused by antineoplastic treatment can negatively affect the nutritional status of cancer patients. Nutritional therapy through the use of bioactive compounds may help to control the adverse effects of an...

Extended apical periodontal cyst in maxilla: case report

The apical periodontal cyst represents the most common inflammatory pathology among odontogenic cysts, corresponding to about 60% of the maxilla and mandible cysts. It is associated with the apex of a devitalized tooth a...

Possible causes and consequences of low measles vaccination coverage: an integrative literature review study

Measles is a viral, infectious, preventable disease that requires high vaccination coverage in order for herd immunity to be achieved and for outbreaks to be prevented. This study aims to identify the possible causes and...

Use of potassuim nitrate in the treatment of dentin hypersensitivity: A literature review

The aim of this study was to conduct a review of the literature on the treatment of dentin hypersensitivity with potassium nitrate-based desensitizing agents. A bibliographic survey of the period from 2003 to 2019 was ca...

Deciduous teeth stem cells, promising source of stem cells: narrative literature review

Among the most progressive types of medical-scientific research, the study with stem cells stands out. Stem cell therapy has emerged as an innovative model in the treatment of diseases and injuries, presenting numerous a...

Download PDF file
  • EP ID EP732441
  • DOI 10.46311/2318-0579.61.eUJ4570
  • Views 33
  • Downloads 0

How To Cite

Maicon Jeferson Silva de Oliveira, Beatriz Birelli do Nascimento, Fernanda de Assis Oliveira, Mahelly Bueno de Almeida, Márcio Rodrigues, Flavia Cristina Cardoso Carvalho, Éric Diego Barioni, Rodrigo Azevedo Loiola, Rômulo Tadeu Dias de Oliveira, Gustavo Henrique Oliveira da Rocha (2024). Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil. Revista Uningá, 61(1), -. https://europub.co.uk/articles/-A-732441